Showing Results for: “exercise”

The No-Cost Diabetes Risk Reduction Program Aims to Slow Trajectory of Childhood Obesity This year, Aurora Public Schools (APS) and the American Diabetes Association ® (ADA), through the Collaboration for Equitable Health, have teamed up to launch the ADA's Project Power for youth initiative at several local schools. During this national Move More Month, students at Jewell Elementary School participated in the program during their third grade physical education (PE) class. “We’re excited to bring Project Power into our school,” said Lacy Jolly, principal at Jewell Elementary School. “Creating

Take control of your health with steps to prevent or delay diabetic nerve damage (neuropathy). Explore practical tips to manage symptoms and protect yourself.

Keys to managing osteoarthritis knee pain for people living with type 2 diabetes. There are many ways living with type 2 diabetes affects overall health—including joint health. Osteoarthritis (OA) is the most common form of arthritis, especially in the knees. OA happens when the protective cushion between your bones wears down over time, leading to stiffness, pain, and swelling. For people managing diabetes, knee pain can make it harder to move, which can affect blood glucose (blood sugar) management and overall wellbeing.

Raghuram Nagarathna, MD, FRCP, DSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Vivian Fonseca and Nagendran Family Diabetes Research Award. This award, given in memory of Mr. P. Nagendran, promotes and recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations, and/or research by a scientist from these areas. The Award honors the contributions of Dr. Vivian Fonseca, a former ADA President, Medicine & Science and the Tullis-Tulane Alumni Chair in Diabetes, Professor of Medicine Chief in the

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s four 2019 Professional Interest Group Awards. Individually and collectively, their exemplary leadership, mentorship and achievements have advanced the field of diabetes care and improved health outcomes for people with diabetes. “The recipients of this year’s Professional Interest Group Awards have each made significant

November is American Diabetes Month®, but it’s not time to celebrate. Diabetes has become the fastest-growing chronic disease in the world, and it is the most expensive chronic disease in the U.S. Over 37 million Americans have diabetes and one in five people don’t even know they have it. Today, diabetes causes more deaths than breast cancer and AIDS combined. And in November alone, 116,500 Americans will be diagnosed with diabetes, and sadly, 23,500 Americans will lose their lives to diabetes-related illness. “Most of us know someone affected by diabetes. At the American Diabetes Association

Exploratory Analysis from the SURPASS-4 Trial Data for Kidney Function with Tirzepatide Compared to Insulin Glargine A pre-specified exploratory analysis from the SURPASS-4 trial showed tirzepatide, a novel once-weekly medication for the treatment of diabetes, improved kidney outcomes for adults with type 2 diabetes who have increased cardiovascular risk. SURPASS-4 was part of the SURPASS global clinical development program for Eli Lilly and Company’s tirzepatide. Findings were presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Chronic kidney disease (CKD)

Learn your risk for diabetes-related eye disease and diabetes. Take the Diabetes-Related Retinopathy Retina Risk test and Diabetes Risk Test using the links listed on the page.